Summary&horbar; We studied the effect of 2 different parenteral regimens upon gastrin, motilin and pancreatic polypeptide (PP) levels in infants. In 15 children, aged 
INTRODUCTION
The digestive processes are at least partially regulated by the secretion of gastrointestinal hormones and the physiology of those hormones remains the subject of extensive research. A recent review was given by Walsh (1987) .
It has been shown that in the newborn, elevations occur in basal plasma gut hormone levels (Rogers et al, 1974; Torsoli et al, 1975; Lucas et al, 1980a, b) and that the normalization to normal adult values and the establishment of the postprandial release pattern develop progressively (Lucas et al, 1978 (Lucas et al, , 1980b ). This development is probably triggered by oral feeding. Indeed, in infants who, on account of hyaline membrane disease received only intravenous glucose, no postnatal changes in motilin, gastrin, enteroglucagon, GIP or neurotensin could be found (Lucas et al, 1980b) .
Parenteral nutrition is a specific method of nutritional support, which has to be used in certain conditions in which oral feeding is contraindicated. As the hormonal changes induced by oral feeding may play a role in the adaptive changes of the gastrointestinal system, parenteral feeding could have negative side-effects.
In fact, it has been shown that total parenteral nutrition causes small intestinal hypoplasia in rats (Johnson et al, 1975) and increases the risk of gallstones developing in children (Roslyn et al, 1983) . In patients with Crohn's disease, no change in fasted and postprandial levels of gut hormones was observed (Greenberg et al, 1981 but little is known about hormone secretion during parenteral feeding in infants. We have therefore studied the effect of 2 different parenteral regimens upon the release of gastrin, motilin and pancreatic polypeptide in infants fed parenterally because of surgery or protracted diarrhea. of infusion. The infusion lasted for a total of 20 h in both studies. Blood samples were collected in a heparinised tube containing trasylol (0.1 ml for each ml blood) and immediately centrifuged. The plasma was immediately frozen at -20 °C and stored until assayed for motilin and PP. A separate serum sample was also prepared for the measurement of gastrin. The radioimmunoassay for gastrin was performed using commercially available reagents (Sorin-CEA). The antibody is directed against the C-terminal end and recognizes gastrin-17 as well as gastrin-34. The cross-reaction is 72% (on a molar basis) for gastrin-34 at 50% inhibition of binding. Our radioimmunoassay of motilin and PP has been previously described (Peeters et al, 1980; Janssens et al, 1982) . The pancreatic polypeptide antibody, porcine pancreatic polypeptide (for labeling) and human pancreatic polypeptide (standard) were a gift from Dr RE Chance (Eli Lilly, Indianapolis, USA). The motilin antibody was prepared in rabbits; it recognizes the C-terminal part of the motilin molecule. Synthetic 13-norleucine-motilin was used for labelling and as standard; it was obtained from Fluka AG (Buchs, Switzerland). The smallest amount of peptide measurable with 95% confidence using duplicate measurements was 10 pg/ml for gastrin, 16 pg/ml for PP, and 2.5 pg/ml for motilin. Reference ranges established in our laboratory for normal adult volunteers are 0-100 pg/ml for gastrin, 0-500 pg/ml for motilin and 0!00 pg/ml for PP. 
RESULTS
Wide interindividual fluctuations were noted for the basal levels of the 3 peptides measured, but for gastrin and motilin, intraindividual variations were low. Indeed for these peptides, a good correlation was found between the pre-infusion levels obtained in each patient before the 2 studies. Thus, for gastrin the levels were 179 ± 44 (time 0, study A) and 176 ± 52 (time 0, study B) pg/ml with a highly significant correlation between both (r = 0.888; P < 0.001). For motilin, the values were respectively 508 ± 76(A) and 516 ± 77(B) pg/ ml and individual values also correlated well between both studies (r = 0.656; P < 0.02). For PP the correspondence between both studies was poor, 256 ± 50(A) and 379 ± 78(B) pg/ml (r= 0.14; P < 0.7). It will be noted that the mean basal levels of gastrin were rather elevated compared to the normal adult values. For motilin a small elevation was found and PP values were normal.
The effect of the infusion of both parenteral regimens on the plasma levels of both hormones is shown in figure 1 . Gastrin levels did not change significantly : from 179 ± 44 to 192 ± 44 (P < 0.3) in study A and from 176 ± 52 to 155 ± 48 in study B (P < 0.7). In both studies, an almost perfect correlation was found between pre-and postinfusion levels (A: r = 0.975; P < 0.001; B: r= 0.963; P < 0.001). ). Motilin levels decreased in both studies : from 508 t 76 to 383 ± 54 pg/ml in study A (P < 0.05) and from 516 + 77 to 441 ±41 (P < 0.2) in study B. The decrease was only significant in study A. As for gastrin, in both studies pre-and post-infusion motilin levels were significantly correlated (A: r = 0.732; P < 0.01; B: r = 0.629; P < 0.05). PP (Lucas et al, 1980a, b) . The time required to reach normal adult values is not known. For gastrin it has been reported that plasma levels are still elevated in children 2-3 yr old (Janik et al, 1977; Lucas et al, 1981) .
In the patients studied, the basal levels of gastrin and motilin were also elevated. The increase was most pronounced for gastrin, confirming the long persistence of hypergastrinemia in infants. Increased hormone levels in the first year of life may be attributed to several factors, such as a greater importance of the endocrine cell mass, or as yet undeveloped regulatory mechanisms of secretion and metabolism.
However, for motilin the increase, which was very moderate, may also be due to the fact that some of our patients suffered from diarrhea, a condition known to cause hypermotilinemia in infants (Lothe et al, 1987) . Nevertheless, when considered separately, values for the 5 patients with protracted diarrhea did not differ from those of the other patients.
Our data show that during parenteral nutrition, the levels of gastrin and PP remain unchanged, regardless of the addition of lipids to the infusate. However, when added, motilin levels decreased significantly. Apart from the effect on motilin levels, the results seem to agree with what is known of the release mechanism of these peptides. Gastrin secretion is mainly stimulated by the presence of proteins or degradation products of proteins in the gastric lumen; its secretion is inhibited by a low gastric pH. When applied to the gastric mucosa, the amino acids phenylalanine and tryptophan are the most potent gastrin-releases (Taylor et al, 1982) , but although they stimulate acid secretion when given intravenously there is no concomitant release of gastrin (McArthur et al, 1983 
